Delaware
|
|
001-34637
|
|
20-1852016
|
(State or Other Jurisdiction of
Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
25801 Industrial Boulevard, Suite B, Hayward,
California
|
|
94545
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02 | Results of Operations and Financial Condition. |
Item 9.01 | Financial Statements and Exhibits. |
(d)
|
Exhibits
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release dated August 9, 2016
|
Date: August 9, 2016
|
Anthera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
|
By:
|
/s/ May Liu
|
|
|
May Liu
|
|
|
Senior Vice President, Finance and Administration
(Principal Accounting Officer)
|